Literature DB >> 24365502

Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.

Sharon W Kwan1, Kelly E Mortell2, Adam D Talenfeld3, Michael C Brunner4.   

Abstract

PURPOSE: To compare survival outcomes of sublobar resection and thermal ablation for early-stage non-small cell lung cancer (NSCLC) in older patients.
MATERIALS AND METHODS: SEER-Medicare linked data for patients with a diagnosis of lung cancer from 2007-2009 were used. Patients ≥ 65 years old with stage IA or IB NSCLC who were treated with sublobar resection or thermal ablation were identified. Primary outcome was overall survival (OS), and secondary outcome was lung cancer-specific survival (LCSS). Demographic and clinical variables were compared. Unadjusted OS and LCSS curves were estimated using the Kaplan-Meier method, and multivariate analysis was performed using the Cox model. OS and LCSS curves for propensity score matched groups were also compared.
RESULTS: The final unmatched study population comprised 1,897 patients. Patients who underwent sublobar resection were significantly younger (P = .006) and significantly less likely to have a comorbidity index > 1 (P = .036), a diagnosis of chronic obstructive pulmonary disease (P = .017), or adjuvant radiation therapy (P < .0001) compared with patients treated with thermal ablation. Unadjusted survival curves of unmatched groups demonstrated significantly better OS (P = .028) and LCSS (P = .0006) in the resection group. Multivariate Cox model adjusting for demographic and clinical variables found no significant difference in OS between the treatment groups (P = .555); a difference in LCSS (hazard ratio = 1.185, P = .026) persisted. Survival curves for matched groups found no significant difference in OS (P = .695) or LCSS (P = .819) between treatment groups.
CONCLUSIONS: After controlling for selection bias, this study found no difference in OS between patients treated with sublobar resection and thermal ablation.
© 2013 The Society of Interventional Radiology Published by SIR All rights reserved.

Entities:  

Keywords:  COPD; HR; LCSS; NSCLC; OS; SEER; Surveillance, Epidemiology and End Results program; chronic obstructive pulmonary disease; hazard ratio; lung cancer–specific survival; non–small cell lung cancer; overall survival

Mesh:

Year:  2014        PMID: 24365502     DOI: 10.1016/j.jvir.2013.10.018

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  17 in total

1.  Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Authors:  Song Gao; Seth Stein; Elena N Petre; Waleed Shady; Jeremy C Durack; Carole Ridge; Prasad Adusumilli; Natasha Rekhtman; Stephen B Solomon; Etay Ziv
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  Understanding the possibility of image-guided thermal ablation for pulmonary malignancies.

Authors:  Hideki Ujiie; Kazuhiro Yasufuku
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

3.  Thermal ablation for the treatment of primary and secondary pulmonary malignancies.

Authors:  Eun Young Kim; Young Saing Kim; Jeong Ho Kim
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.

Authors:  Damian E Dupuy; Hiran C Fernando; Shauna Hillman; Thomas Ng; Angelina D Tan; Amita Sharma; William S Rilling; Kelvin Hong; Joe B Putnam
Journal:  Cancer       Date:  2015-06-19       Impact factor: 6.860

Review 5.  Decision Making in Interventional Oncology: Ablative Options in the Lung.

Authors:  Kyungmouk Steve Lee; Joseph P Erinjeri
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

Review 6.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation.

Authors:  Henry S Park; Frank C Detterbeck; David C Madoff; Brett C Bade; Ulas Kumbasar; Vincent J Mase; Andrew X Li; Justin D Blasberg; Gavitt A Woodard; Whitney S Brandt; Roy H Decker
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

7.  Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?

Authors:  Rameses Sroufe; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 8.  Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?

Authors:  J Palussière; M Cazayus; S Cousin; M Cabart; F Chomy; V Catena; X Buy
Journal:  Curr Oncol Rep       Date:  2021-05-05       Impact factor: 5.075

9.  Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous, and synchronous lung tumors.

Authors:  Carole A Ridge; Mikhail Silk; Elena N Petre; Joseph P Erinjeri; William Alago; Robert J Downey; Constantinos T Sofocleous; Raymond H Thornton; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2014-04-02       Impact factor: 3.682

Review 10.  Radiofrequency ablation for early-stage nonsmall cell lung cancer.

Authors:  Takao Hiraki; Hideo Gobara; Toshihiro Iguchi; Hiroyasu Fujiwara; Yusuke Matsui; Susumu Kanazawa
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.